Transplanting Tissue: Safety on the Public Radar Screen
This article was originally published in Start Up
Blood safety has been on the public radar screen for more than a decade, and the focus of vast amounts of financial and human resources. But the infectious disease risks associated with tissue transplants are only now receiving widespread attention because of the troubles of CryoLife Inc. While the publicity and lack of government oversight may frighten people in the near-term, it also provides opportunities for companies to make changes that improve tissue safety.
You may also be interested in...
With AIDS and HCV under control, companies large and small are looking to protect the blood supply from a range of known and as yet unknown pathogens, which pose potential threats. Near-term attention is focusing on emerging pathogen inactivation technologies, which are moving closer to the clinic, even as questions linger about their cost effectiveness and toxicity.
Orthopedic Implants. Osteoimplant offers both standard and custom, specialty orthopedic implants including hip and shoulder implants, and trauma products, including wires, pins, plates and splints.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.